Update to monograph requirements for listed probiotic medicines
Published
Related content
-
Consent relating to listed medicines that contain whole live microorganisms as an active ingredient
This consent is given under sections 14 and 14A of the Therapeutic Goods Act 1989. -
Therapeutic Goods (Poisons Standard) (COVID-19 Vaccine - Pfizer) Labelling Exemption 2021
This labelling exemption is granted under section 1.5.5 of Part 2 of the current Poisons Standard -
Therapeutic Goods (Poisons Standard) (COVID-19 Vaccine - Moderna) Labelling Exemption 2021
This labelling exemption is granted under section 1.5.5 of Part 2 of the current Poisons Standard.